Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Shared Decision Making for Patients With First-admission Schizophrenia [Phase 2, Phase 3]
An update on a Phase 2/Phase 3 trial evaluating shared decision making for patients with first-admission schizophrenia; the Yokohama City Un…
-
FDA approval · 2015-12-23FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) from H2-Pharma LLC. This action approves the supplemen…
-
CLINICAL_TRIALS trial_result · 2015-12-21Clinical Trial Update: Efficacy of Pregnenolone in Patients With Schizophrenia [Phase 2]
A Phase 2 clinical trial evaluating pregnenolone for efficacy in schizophrenia and schizoaffective disorder has completed. The study was spo…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating culturally based family therapy to improve treatment outcomes for …
-
CLINICAL_TRIALS withdrawal · 2015-12-17Clinical Trial Update: Efficacy & Safety of SCH 900435 in Schizophrenia (Study P06079)(WITHDRAWN) [Phase 2]
A Phase 2 trial evaluating SCH 900435 for schizophrenia has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-12-17FDA Approved: PERPHENAZINE — Original Application (Wilshire Pharmaceuticals, Inc.)
The FDA approved a generic version of perphenazine under ANDA205973 from Wilshire Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study
This observational study describes real-world use of quetiapine extended-release in France for schizophrenia and bipolar disorder, summarizi…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: Effect of Memantine on ERP in Early Schizophrenia and Healthy Subjects [NA]
This clinical trial evaluates the effect of memantine on event-related potentials in individuals with early schizophrenia and in healthy con…
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: Regulation of Arginine-vasopressin (AVP) [NA]
Completed Yale-sponsored clinical trial studying the regulation of arginine-vasopressin (AVP) in schizophrenia and depression.
-
CLINICAL_TRIALS withdrawal · 2015-12-09Clinical Trial Update: Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients [NA]
A clinical trial comparing clozapine with amisulpride in treatment-resistant schizophrenia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: The Effect of Paliperidone Palmitate in Schizophrenia [Phase 4]
A Phase 4 clinical trial evaluating paliperidone palmitate for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: Resveratrol, Cardiovascular Risk Markers And Cognitive Performance In Patients With Schizophrenia [Phase 2]
A Phase 2 clinical trial evaluating resveratrol's effects on cardiovascular risk markers and cognitive performance in patients with schizoph…
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: Switching From Consta® to Sustenna® in Patients With Schizophrenia
This clinical trial update reports the completion of a study evaluating switching from Risperdal Consta to Invega Sustenna in patients with …
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia [Phase 3]
A Phase 3 head-to-head trial comparing aripiprazole once-monthly and paliperidone palmitate in adults with schizophrenia, with results poste…
-
CLINICAL_TRIALS trial_result · 2015-12-01Clinical Trial Update: Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia [Phase 3]
A Phase 3 clinical trial update showing results for brexpiprazole in adults with acute schizophrenia; results were posted in December 2015.
-
FDA approval · 2015-11-27FDA Approved: OLANZAPINE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for olanzapine from Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia [Phase 3]
A Phase 3 efficacy study of OPC-34712 in adults with schizophrenia has completed and results were posted in 2015.
-
FDA approval · 2015-11-25FDA Approved: CLOZAPINE — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's original application for clozapine, granting approval for a generic clozapine product.
-
CLINICAL_TRIALS research · 2015-11-23Clinical Trial Update: A Pharmacokinetic Study of Paliperidone ER [Phase 4]
A Phase 4 pharmacokinetic study of Paliperidone ER for schizophrenia and schizoaffective disorder, sponsored by National Taiwan University H…
-
FDA approval · 2015-11-19FDA Approved: ZIPRASIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for ziprasidone from Dr. Reddy's Laboratories Limited, approving a generic version under the AND…
-
FDA approval · 2015-11-10FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
The FDA approved a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics (USA), Inc. The action indicates an appro…
-
FDA approval · 2015-11-05FDA Approved: OLANZAPINE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for the generic olanzapine product manufactured by Macleods Pharmaceuticals Limited under ANDA 20286…
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia [NA]
An open-label pilot trial evaluated alpha-lipoic acid for weight loss in individuals with schizophrenia. The study has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: Lifestyle Modification for Weight Loss in Schizophrenia [NA]
A Yale University-sponsored clinical trial update reports the completion of a study evaluating lifestyle modification for weight loss in ind…
-
FDA approval · 2015-11-03FDA Approved: CHLORPROMAZINE HCI — Supplemental Application (Dr. Reddy's Laboratories Inc.,)
FDA approved a supplemental application for chlorpromazine HCl from Dr. Reddy's Laboratories, authorizing the generic version to be marketed…